ロード中...
Effects of vildagliptin as add-on treatment in patients with type 2 diabetes mellitus: insights from long-term clinical studies in Japan
BACKGROUND: Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is wildly used to treat type 2 diabetes mellitus (T2DM) with mono- or combination-therapy. We review two previously published open-label studies to extract insights on the long-term efficacy and safety of vildagliptin. METHODS: Tw...
保存先:
| 出版年: | J Diabetes Metab Disord |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4932694/ https://ncbi.nlm.nih.gov/pubmed/27382546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40200-016-0240-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|